Immune checkpoint blockers in patients with unresectable or metastatic thymic epithelial tumours: A meta-analysis
Jordi Remón, Guillermo Villacampa, Francesco Facchinetti, Massimo Di Maïo, Florit Marcuse, Marcello Tiseo, Monique Hochstenbag, Lizza Hendriks, Benjamin Besse
Topics & Concepts
Thymic carcinomaNivolumabPembrolizumabMedicineAtezolizumabThymomaInternal medicineAvelumabOncologyAdverse effectMetastatic Urothelial CarcinomaContext (archaeology)ChemotherapyCarcinomaImmunotherapySurgeryCancerBladder cancerBiologyUrothelial carcinomaPaleontologyMyasthenia Gravis and ThymomaCancer, Stress, Anesthesia, and Immune ResponseCancer Immunotherapy and Biomarkers